A carregar...
Fibrolamellar hepatocellular carcinoma treated with atezolizumab and bevacizumab: two case reports
BACKGROUND: Fibrolamellar hepatocellular carcinoma is a unique tumor of the liver that differs from the classical hepatocellular carcinoma in diagnosis, behavior, and possibly treatment. There is usually absent underlying liver disease, and it usually occurs in young patients. The survival outcomes...
Na minha lista:
| Publicado no: | J Med Case Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7962306/ https://ncbi.nlm.nih.gov/pubmed/33722275 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02695-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|